Potent Antiviral Activity of ABT-493 and ABT-530 With 3-Day Monotherapy in Patients With and Without Compensated Cirrhosis With Hepatitis C Virus (HCV) Genotype 1 Infection

Press/Media: Press / Media

PeriodMay 4 2015

Media coverage

1

Media coverage

  • TitlePotent Antiviral Activity of ABT-493 and ABT-530 With 3-Day Monotherapy in Patients With and Without Compensated Cirrhosis With Hepatitis C Virus (HCV) Genotype 1 Infection
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date5/4/15
    PersonsEric J Lawitz